{"id":"W2608337225","doi":"10.1097/01.cot.0000516713.11719.72","title":"Phase III SOLO-2 Data Demonstrates High Survival Benefit of Olaparib","year":2017,"lang":"en","type":"article","venue":"Oncology Times","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Olaparib; Tolerability; Medicine; Oncology; Internal medicine; Ovarian cancer; Clinical endpoint; BRCA mutation; Placebo; PARP inhibitor; Clinical trial; Cancer; Adverse effect; Pathology; Biology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004253153,0.0001433306,0.0005726826,0.00006219412,0.000203359,0.00001715723,0.0005618923,0.000201051,0.001953798],"category_scores_gemma":[0.000131482,0.0001276266,0.00005576415,0.0000403322,0.0006128988,0.000195221,0.0002018323,0.0001987167,0.00009021537],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007180193,"about_ca_system_score_gemma":0.0003768113,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002675395,"about_ca_topic_score_gemma":0.0001114513,"domain_scores_codex":[0.9988444,0.00004350649,0.0003478263,0.0003417902,0.0001769029,0.0002455087],"domain_scores_gemma":[0.9976558,0.0001832457,0.0003812074,0.001542106,0.0001237207,0.0001139222],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01107343,0.008989904,0.05218063,0.0002499241,0.002272005,0.0006498053,0.0007815122,0.00001616487,0.2180039,0.037396,0.3318257,0.336561],"study_design_scores_gemma":[0.1400495,0.01075666,0.04492149,0.0005453458,0.001336832,0.0005001565,0.0006110145,0.001898116,0.2349695,0.01370745,0.549676,0.001027959],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8169078,0.0007851264,0.0002747159,0.01008715,0.001291944,0.0004332608,0.0004700027,0.00009165893,0.1696583],"genre_scores_gemma":[0.9898049,0.0002734254,0.002582393,0.0003379826,0.0004140433,0.00001895933,0.0002886228,0.0000208382,0.006258876],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.335533,"threshold_uncertainty_score":0.9989585,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09102410319965419,"score_gpt":0.4192331876939281,"score_spread":0.3282090844942739,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}